Global Musculoskeletal Disorders Therapeutics Market 2016-2020
- SKU ID : TNV-IRTNTR10170 10293268
- |
- Publishing Date: 31-Aug-2016
- |
- Region: Global
- |
- No. of pages: 120
About Musculoskeletal Disorders
Musculoskeletal disorders are the group of pain disorders or injuries that affect the body's joints, muscles, nerves, ligaments, tendons, and structures, all of which support the hands, legs, neck and back. The pain and discomfort vary with the severity of the condition. These disorders have a wide range of causes, but usually occur depending on the age, lifestyle, and occupation of an individual. Symptoms usually range from recurrent pain, stiffness, and swellings. X-rays and other medical imaging procedures may diagnose the condition. The treatment mainly depends on the severity of the condition. Apart from the drugs, physical therapy, and occupational therapy are also used to manage the condition.
Technavio’s analysts forecast the global musculoskeletal disorder therapeutics market to grow at a CAGR of 4.46% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global musculoskeletal disorder therapeutics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs used to treat musculoskeletal disorders including osteoarthritis, rheumatoid arthritis, osteoporosis, ankylosing spondylitis, psoriatic arthritis, and fibromyalgia.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Musculoskeletal Disorder Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• AbbVie
• Johnson & Johnson
• Amgen
• Pfizer
• F. Hoffmann-La Roche
• Eli Lilly
Other prominent vendors
• 3SBio
• AB Sciences
• AbGenomics International
• Ablynx
• Adheron
• Akron Molecules AG
• Alder BioPharmaceuticals
• Amgen Astellas BioPharma K.K. in Japan
• Ampio Pharmaceuticals
• Antares Medical Services
• Astellas
• AstraZeneca
• Baxter
• Biocad
• Bioiberica
• Boehringer Ingelheim
• Bone Therapeutics
• Can-Fite BioPharma
• Celgene
• Celltrion
• Cellular Biomedicine
• Cerapedics
• ChemoCentryx
• Chugai Pharmaceutical
• Coherus Biosciences
• Daiichi Sankyo
• Dong-A ST
• Edding Pharm
• Eisai
• Epirus
• Eupraxia Pharmaceuticals
• Flexion Therapeutics
• Galapagos NV
• Gedeon Richter
• Gilead Sciences
• GlaxoSmithKline
• Histogenics
• IBSA Institut Biochimique
• iCeutica
• Iltoo Pharma
• Incyte
• Innovative Med Concepts
• Iroko Pharmaceuticals
• ISTO Technologies
• KaloBios Pharmaceuticals
• KAN Research Institute
• Kang Stem Biotech
• Kitov Pharmaceuticals
• Lexicon Pharmaceuticals
• LG Life Sciences
• MEDIPOST
• Medivir
• Merck
• Mereo
• Mesoblast
• MOCHIDA PHARMACEUTICAL
• MorphoSys
• Morphotek
• Mycenax
• Neomed Institute
• Novartis
• Omeros
• OrthoTrophix
• Osteologix
• OxyPharma
• PFEnex
• Philogen
• PhytoHealth
• Plexxikon
• PLx Pharma
• Protalex
• Proximagen
• Radius Health
• Regeneron Pharmaceuticals
• Samsung Bioepis
• Samumed
• Sandoz
• Sanofi
• SantoSolve AS
• Steminent Biotherapeutics
• Stempeutics Research
• Taiwan Liposome Company
• Takeda
• Tarsa Therapeutics
• Techfields Pharma
• Tetec AG
• TheraMAB
• TiGenix
• TissueGene
• Tonix Pharmaceuticals
• Translational Biosciences
• UCB
• Vericel
• Vertex Pharmaceuticals
• Vitaeris
• Winston Laboratories
• Zosano Pharma
Market driver
• Tentative approval of advanced drugs
• For a full, detailed list, view our report
Market challenge
• Growing preference toward surgeries
• For a full, detailed list, view our report
Market trend
• Ongoing active clinical trials for biosimilars
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Musculoskeletal disorders are the group of pain disorders or injuries that affect the body's joints, muscles, nerves, ligaments, tendons, and structures, all of which support the hands, legs, neck and back. The pain and discomfort vary with the severity of the condition. These disorders have a wide range of causes, but usually occur depending on the age, lifestyle, and occupation of an individual. Symptoms usually range from recurrent pain, stiffness, and swellings. X-rays and other medical imaging procedures may diagnose the condition. The treatment mainly depends on the severity of the condition. Apart from the drugs, physical therapy, and occupational therapy are also used to manage the condition.
Technavio’s analysts forecast the global musculoskeletal disorder therapeutics market to grow at a CAGR of 4.46% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global musculoskeletal disorder therapeutics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs used to treat musculoskeletal disorders including osteoarthritis, rheumatoid arthritis, osteoporosis, ankylosing spondylitis, psoriatic arthritis, and fibromyalgia.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Musculoskeletal Disorder Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• AbbVie
• Johnson & Johnson
• Amgen
• Pfizer
• F. Hoffmann-La Roche
• Eli Lilly
Other prominent vendors
• 3SBio
• AB Sciences
• AbGenomics International
• Ablynx
• Adheron
• Akron Molecules AG
• Alder BioPharmaceuticals
• Amgen Astellas BioPharma K.K. in Japan
• Ampio Pharmaceuticals
• Antares Medical Services
• Astellas
• AstraZeneca
• Baxter
• Biocad
• Bioiberica
• Boehringer Ingelheim
• Bone Therapeutics
• Can-Fite BioPharma
• Celgene
• Celltrion
• Cellular Biomedicine
• Cerapedics
• ChemoCentryx
• Chugai Pharmaceutical
• Coherus Biosciences
• Daiichi Sankyo
• Dong-A ST
• Edding Pharm
• Eisai
• Epirus
• Eupraxia Pharmaceuticals
• Flexion Therapeutics
• Galapagos NV
• Gedeon Richter
• Gilead Sciences
• GlaxoSmithKline
• Histogenics
• IBSA Institut Biochimique
• iCeutica
• Iltoo Pharma
• Incyte
• Innovative Med Concepts
• Iroko Pharmaceuticals
• ISTO Technologies
• KaloBios Pharmaceuticals
• KAN Research Institute
• Kang Stem Biotech
• Kitov Pharmaceuticals
• Lexicon Pharmaceuticals
• LG Life Sciences
• MEDIPOST
• Medivir
• Merck
• Mereo
• Mesoblast
• MOCHIDA PHARMACEUTICAL
• MorphoSys
• Morphotek
• Mycenax
• Neomed Institute
• Novartis
• Omeros
• OrthoTrophix
• Osteologix
• OxyPharma
• PFEnex
• Philogen
• PhytoHealth
• Plexxikon
• PLx Pharma
• Protalex
• Proximagen
• Radius Health
• Regeneron Pharmaceuticals
• Samsung Bioepis
• Samumed
• Sandoz
• Sanofi
• SantoSolve AS
• Steminent Biotherapeutics
• Stempeutics Research
• Taiwan Liposome Company
• Takeda
• Tarsa Therapeutics
• Techfields Pharma
• Tetec AG
• TheraMAB
• TiGenix
• TissueGene
• Tonix Pharmaceuticals
• Translational Biosciences
• UCB
• Vericel
• Vertex Pharmaceuticals
• Vitaeris
• Winston Laboratories
• Zosano Pharma
Market driver
• Tentative approval of advanced drugs
• For a full, detailed list, view our report
Market challenge
• Growing preference toward surgeries
• For a full, detailed list, view our report
Market trend
• Ongoing active clinical trials for biosimilars
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
